Pharmac delays controversial diabetes drug decision until February

+News

Pharmac delays controversial diabetes drug decision until February

February
Feedback has led Pharmac to push back its decision on funding new diabetes drugs has until February
“Pharmac director of operations Lisa Williams says although most feedback was positive, some ‘important concerns were raised’” Pharmac is taking